Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic

Launched by NORDSJAELLANDS HOSPITAL · Jun 12, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how hospital staff at a large hospital in Denmark have developed antibodies against the COVID-19 virus. By testing samples from healthcare workers, the researchers aim to identify who has built up protection against the virus and who might still be at risk of infection. This information is important because it helps ensure that those who are not infected can safely care for patients, while also keeping the hospital environment safe during the pandemic.

To participate in this trial, you need to be a hospital employee. There are no specific exclusions, so if you work at the hospital, you may be eligible to join. If you decide to participate, you can expect to undergo regular testing for COVID-19 antibodies, which will help the hospital manage care and treatment more effectively during this challenging time. Your involvement could contribute valuable information to improve safety for both staff and patients in the hospital.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: hospital employee
• • -
• • Exclusion Criteria: none